Human Factor VII (Factor 7) ELISA Kit (High Sensitivity; with Controls)

Indicators of Endothelial dysfunction and factors hemostasis in patients with stable and unstable atherosclerotic plaques

• https://iimed.ru/assets/docs/Dissovet/Dissertacii/Striukova_EV_dissertacia_21.01.2021.pdf
• Vitalievna SE (2021). Scientific Research Institute of therapy and preventive medicine. Thesis.
• No Snippet Provided

Indicator of endothelial dysfunction and factors hemostasis in patients iwht stable and unstable atherosclerotic plates

• https://iimed.ru/assets/docs/Dissovet/Dissertacii/Striukova_EV_dissertacia_21.01.2021.pdf
• Stryukova EV (2021). Federal Research Center Institue of Cytology and Genetics of the Siberian Branch Russian Academy of Sciences. Dissertation.
• No Snippet Provided

STUDY OF IMMUNOGENICITY OF THE RUSSIAN RECOMBINANT ACTIVATED COAGING FACTOR VII IN PATIENTS WITH HEMOPHILIA A COMPLICATED BY THE DEVELOPMENT OF INHIBITORS

• https://web.b.ebscohost.com/abstract?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=0031403X&AN=142465129&h=%2fQQVvXSTZ6ydFgjbwlDMzgekAihw2ifvO%2bsDCx8u2FMit95wRCHTmiRKw333znY8delZsxqBRyT2un%2bdbANESQ%3d%3d&crl=c&resultNs=AdminWebAuth&resultLocal=ErrCrlNotAuth&crlhashurl=login.aspx%3fdirect%3dtrue%26profile%3dehost%26scope%3dsite%26authtype%3dcrawler%26jrnl%3d0031403X%26AN%3d142465129
• Andreeva TA et al. (2020). Pediatriya. 99(2):206-215
• No Snippet Provided

Interrelation of genetic prothrombotic polymorphisms with the state of thrombocytic and plasma links of hemostasis in patients with a functionally single ventricle of the heart

• http://www.tnimc.ru/nauka/dissertatsionnyy-sovet-2/zashchity/Avtoref-Lugacheva.pdf
• Gennadievna LY (2018). Tomsk National Research Medical Center of the Russian Academy of Sciences
• No Snippet Provided

Long-Acting Coagulation Factors and Methods of Producing Same

• http://www.freepatentsonline.com/8759292.html
• Fima UE et al. (2010). Patent No: US 8476234 B2
• No Snippet Provided

Cell culture processes

• https://www.google.si/patents/US20090176269
• Giovagnoli A et al. (2009). USPTO Patent Applicaton #: US20090176269 A1
• No Snippet Provided

Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease

• https://pubmed.ncbi.nlm.nih.gov/18424361/#affiliation-1
• He WJ et al. (2008). Eur J Med Res. 13:47-51
• No Snippet Provided

Cellular effects of tissue factor binding proteins. University of South Florida

• https://www.proquest.com/openview/b0e8a5eceb67dcc12576fd6de9bf8427/1?pq-origsite=gscholar&cbl=18750&diss=y
• Meyer TV (2002). ProQuest Dissertations Publishing, 3052656.
• No Snippet Provided

Cyclodextrin-micellar electrokinetic chromatography of apolipoproteins on human very low-density lipoprotein.

• https://pubmed.ncbi.nlm.nih.gov/32390137/
• Ying-Tzu Shieh, Chiz-Tzung Chang, ..., Mine-Yine Liu (2021). Electrophoresis. 2021 Mar 22
• In the study, the Human Factor VII Factor 7 AssayMax ELISA Kit from Assaypro was used to measure the concentrations of apolipoproteins CI, CIII, and E in human very low-density lipopro…

Novel mutation in coagulation factor VII (Carmel mutation): Identification and characterization

• https://pubmed.ncbi.nlm.nih.gov/34027285/
• Aliza Cassel, Nurit Rosenberg, ..., Meir Preis (2021). Research and Practice in Thrombosis and Ha…. 2021 Feb 25
• .. assay using factor VII–depleted plasma (Instrumentation Laboratory) and each of the above‐mentioned PT reagents.. Factor VII antigen was determined using the AssayMax human factor VII ELISA kit (Assaypro, St. Charles, MO, USA).. Factor VIIa activity was determined using the STACLOT VIIa‐rTF kit (Diagnostica Stago, Gennevilliers, France).Factor ..

Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa Activity

• https://pubmed.ncbi.nlm.nih.gov/31266079/
• Sophie Featherby, Yahya Madkhali (2019). Thrombosis and haemostasis. 2019 Jul 02
• The membranes were developedwith alkaline phosphatase-conjugated goat anti-mouse or goat anti-rabbit antibodies (Santa Cruz), respectively, diluted 1:4,000 (v/v) and bands were visualised using the Western Blue stabilised alkaline phosphatase substrate (Promega, Southampton, United Kingdom). fVII/fVIIa antigen levels were determined using the Assaymax FVII-ELISA kit (Assaypro/Universal Biologicals Ltd., Cambridge, United Kingdom) according to the manufacturer’s instructions.

Association of some hemostasis and endothelial dysfunction factors with probability of presence of vulnerable atherosclerotic plaques in patients with coronary atherosclerosis

• https://pubmed.ncbi.nlm.nih.gov/31196144/
• Yu I Ragino, E V Striukova, ..., E V Kashtanova (2019). BMC research notes. 2019 Jun 13
• ampling from a vein to obtain plasma and serum. Following hemostasis factors: factor II, factor VII, factor XII, and antithrombin III in the blood plasma were determined by ELISAs method (test system AssayPro). Following endothelial dysfunction factors: endothelin 1 (Biomedica), MCP-1 (Bender Medsystems), sVCAM-1 (Biosource), ADMA (Immunodiagnost), homocysteine (Ahis-Shield), and PAI-1 (Technoclone

The Ratio of Factor VIIa:Tissue Factor Content within Microvesicles Determines the Differential Influence on Endothelial Cells

• https://pubmed.ncbi.nlm.nih.gov/31259295/
• Yahya Madkhali, Sophie Featherby, John Greenman (2019). TH open : companion journal to thrombosis …. 2019 May 15
• Quantitative Determination of TF and fVIIa Antigen Levels in the Microvesicles The TF antigen associated with the microvesicles was measured using the Quantikine TF-ELISA kit (R & D Systems) and the factor VII/VIIa antigen levels were determined using the Assaymax FVII-ELISA kit (Assaypro/Universal Biologicals Ltd., Cambridge, United Kingdom) according to the manufacturers' instructions.

Wine consumption reduced postprandial platelet sensitivity against platelet activating factor in healthy men

• https://pubmed.ncbi.nlm.nih.gov/26936842/
• Marianna N. Xanthopoulou, Konstantia Kalathara (2016). European journal of nutrition. 2016 Mar 02
• Abstract: Platelet activating factor (PAF) is a potent inflammatory and thrombotic mediator that participates in the initiation and prolongation of atherosclerosis. The aim of the present study was to…

Usefulness and accuracy of the international normalized ratio and activity percent of prothrombin time in patients with liver disease

• https://pubmed.ncbi.nlm.nih.gov/23521497/
• Yasuhiro Takikawa, Mari Harada, ..., Kazuyuki Suzuki (2013). Hepatology Research. 2013 Mar 24
• Abstract: In order to determine the most reliable reporting style for prothrombin time (PT) in patients with liver disease, we examined the correlations between the plasma antigen levels of clotting f…

Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes.

• https://pubmed.ncbi.nlm.nih.gov/21823675/
• Andreas Oberbach, Matthias Blüher, ..., Martin von Bergen (2011). Journal of Proteome Research. 2011 Dec 16
• In the study examining the relationship between the complement system and obesity, the Human Kininogen HMW AssayMax ELISA Kit from Assaypro played a significant role in proteome valida…

A novel missense mutation close to the charge-stabilizing system in a patient with congenital factor VII deficiency

• https://pubmed.ncbi.nlm.nih.gov/21372693/
• Minghua Jiang, Zhaoyue Wang, ..., Changgeng Ruan (2011). Blood Coagulation Fibrinolysis. 2011 Jun 01
• Abstract: Congenital factor VII (FVII) deficiency is a rare autosomal recessive bleeding disorder. Its clinical manifestation and mutational spectrum are highly variable. The purpose of this study was…

R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study

• https://pubmed.ncbi.nlm.nih.gov/21477332/
• Juan Criado-García, Francisco Fuentes, ..., Francisco Pérez-Jiménez (2011). Lipids in health and disease. 2011 Apr 09
• Determination of plasma FVII Ag concentrations FVII Ag levels were determined using an Elisa Kit (AssayMax Human Factor VII ELISA Kit® , Assaypro) with a minimum detectable dose < 6 ng/ml and an intra and inter-assay coefficients of variation of 5.0 % and 7.1% respectively.

Tissue factor in predicted severe acute pancreatitis

• https://pubmed.ncbi.nlm.nih.gov/21182229/
• Ellen Andersson, Jakob Axelsson, ..., Roland Andersson (2010). World Journal of Gastroenterology : WJG. 2010 Dec 28
• 19.1 cm). The plasma was decanted and stored at -70°C until further analysis. TF and FVII were assessed by enzyme-linked immunosorbent assay (ELISA)-kits according to the manufacturer’s instructions (Assaypro St. Charles, MO, USA). The TF-ELISA recognizes TF-apo, TF and TF-VII complexes. The FVII-ELISA detects free FVII and FVIIa, as well as complexes with TF, TF/factor VII and TF/FVIIa. Fibrinogen